Atherosclerosis

Clinical Trial Finder

Many patients with atherosclerosis are interested in participating in the latest research regarding their condition. This Clinical Trial Finder can help you—or a loved one—easily find ongoing cardiovascular clinical research trials for which you might qualify. This list is a service of the U.S. National Institutes of Health called clinicaltrials.gov, a database of publicly and privately supported clinical studies.

Simply click on the trial below that interests you to learn how you might participate.

Atherosclerosis in Familial Hypercholesterolemia

Condition:   Familial Hypercholesterolemia
Intervention:   Other: CT coronary angiogram and carotid ultrasound
Sponsor:   University College, London
Recruiting - verified July 2015

Genetical, Anthropometrical and Biochemical Factors Influencing High Risk Subclinical Atherosclerosis

Condition:   Primary Prevention
Intervention:  
Sponsors:   Instituto Dante Pazzanese de Cardiologia;   State University of Campinas
Completed - verified June 2015

CER-001 Atherosclerosis Regression ACS Trial

Condition:   Acute Coronary Syndromes
Intervention:   Drug: CER-001
Sponsors:   Cerenis Therapeutics, SA;   South Australian Health and Medical Research Institute
Not yet recruiting - verified June 2015

Family-based Approach to Promotion of Health Project 2

Conditions:   Lifestyle Intervention;   Atherosclerosis;   Cardiovascular Risk Factor
Interventions:   Behavioral: Intensive Individual Intervention Program;   Behavioral: Peer-To-Peer Program Intervention
Sponsors:   Icahn School of Medicine at Mount Sinai;   American Heart Association
Not yet recruiting - verified June 2015

Stroke Imaging Package Study

Conditions:   Atherosclerosis;   Stroke;   Infarction, Middle Cerebral Artery;   Vertebrobasilar Insufficiency;   Cerebral Small-vessel Disease;   Moyamoya Syndrome
Intervention:  
Sponsors:   Wei-Hai Xu;   Peking University First Hospital;   Peking Union Medical College Hospital;   General Hospital of Chinese Armed Police Forces;   Daping Hospital and the Research Institute of Surgery of the Third Military Medical University;   General Hospital of Shenyang Military Region;   Subei People's Hospital of Jiangsu Province;   Second Affiliated Hospital, School of Medicine, Zhejiang University;   Beijing Jishuitan Hospital;   Beijing Friendship Hospital;   Fuxing Hospital of Capital Medical University;   Fujian Medical University;   Jingan District Central Hospital of Shanghai (Jingan Branch of Huashan Hospital Affiliated to Fudan University);   First Hospital of Jilin University;   The First Affiliated Hospital of University of South China;   Qilu Hospital of Shandong University (Qingdao);   Tangshan Gongren Hospital;   Wuhan University;   Third Affiliated Hospital, Sun Yat-Sen University;   Renmin Hospital of Wuhan University;   Qilu Hospital;   Qingdao Municipal Hospital
Not yet recruiting - verified June 2015

Impact of Daylight on Patients With Acute Myocardial Infarction

Conditions:   Coronary Arteriosclerosis;   Myocardial Infarction
Interventions:   Other: Day Light;   Other: Room Light
Sponsor:   University of Colorado, Denver
Not yet recruiting - verified June 2015

Optimal Dose of Acetylsalicylic Acid After Coronary Artery Bypass Grafting

Condition:   Stable Coronary Artery Disease With Coronary Artery Bypass Grafting
Intervention:   Drug: Acetylsalicylic acid
Sponsors:   Karolinska University Hospital;   Karolinska Institutet
Active, not recruiting - verified June 2015

Treatment of Coronary ARtery bIfurcation Narrowing by AXxess Stent Implantation

Condition:   Coronary Artery Disease
Intervention:   Device: AXXESS stent
Sponsor:   Clinica Mediterranea
Completed - verified June 2015

Acute Vascular Response to Exercise in Women With Nonobstructive Coronary Artery Disease

Condition:   Nonobstructive Coronary Artery Disease
Intervention:   Other: Slow-paced walking
Sponsor:   University of Florida
Recruiting - verified June 2015

A Prospective, Single-Blinded, Multi-Center, Randomized, Controlled, Registered Clinical Trial on the Efficacy and Safety of Sirolimus-Eluting Stent (MiStent® System) in the Treatment of Patients With Coronary Heart Disease

Condition:   Coronary Heart Disease
Interventions:   Device: MiStentTM;   Device: TIVOLI
Sponsors:   Micell Technologies;   Hefei Life Science Medical Instruments Co. Ltd.;   Giant Med-Pharma Services Inc.;   CCRF Consulting Co., Ltd.
Not yet recruiting - verified June 2015

Telemedicine Qualifying Transition Between Tertiary and Primary Health Care in Stable Coronary Artery Disease Patients

Condition:   Coronary Artery Disease
Intervention:   Other: Telemedicine
Sponsors:   Hospital de Clinicas de Porto Alegre;   Conselho Nacional de Desenvolvimento Científico e Tecnológico;   Ministry of Health, Brazil;   Federal University of Rio Grande do Sul
Recruiting - verified July 2015

Plasma and Platelet microRNAs in Clopidogrel Low Response Patients

Condition:   Coronary Artery Disease
Interventions:   Drug: Clopidogrel;   Drug: acetylsalicylic acid (ASA)
Sponsors:   The First Hospital of Nanjing Medical University;   National Natural Science Foundation of China
Recruiting - verified July 2015

Safety, Hemodynamic Effects and Efficacy of Intramuscular PDA-002 in Subjects Who Have Diabetic Foot Ulcer With Peripheral Arterial Disease

Conditions:   Diabetic Foot;   Peripheral Arterial Disease
Interventions:   Drug: PDA-002;   Drug: Placebo
Sponsor:   Celgene Corporation
Recruiting - verified June 2015

Vascular Ultrasound Screening in Patients With Ischemic Cerebrovascular Disease: a Multi-center Registry Study

Condition:   Stroke
Intervention:  
Sponsors:   Xuanwu Hospital, Beijing;   The First Affiliated Hospital of Shanxi Medical University;   Liaocheng Brains Hospital;   Tianjin Huanhu Hospital;   Baotou City Central Hospital;   First Hospital of Jilin University;   First Affiliated Hospital of Harbin Medical University;   First Hospital of China Medical University;   LanZhou University;   First Affiliated Hospital of Xinjiang Medical University;   The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School;   The First Affiliated Hospital of Soochow University;   Anhui Provincial Hospital;   Guangdong Provincial Hospital of Traditional Chinese Medicine;   Zhuhai  People's Hospital;   Fujian Provincial Hospital;   Mianyang Central Hospital;   The Second Affiliated Hospital of Kunming Medical University;   Brains Hospital of Hunan Province;   Henan Provincial Hospital;   Luoyang Central Hospital Affiliated to Zhengzhou University;   National Health and Family Planning Commission Stroke Prevention Engineering Committee
Recruiting - verified July 2015

Evaluation of Safety and Effectiveness of the BioMimics 3D Stent System

Condition:   Peripheral Arterial Disease
Intervention:   Device: BioMimics 3D Stent System
Sponsors:   Veryan Medical Ltd.;   ClinLogix. LLC;   Yale Cardiovascular Research Group;   Massachusetts General Hospital
Recruiting - verified June 2015

Inflammation in Type 2 Myocardial Infarction

Conditions:   Myocardial Infarction;   Inflammation;   Critical Illness
Intervention:  
Sponsor:   New York University School of Medicine
Withdrawn - verified July 2015

Fractional Flow Reserve Versus Angiography Randomization for Graft Optimization Trial

Conditions:   Coronary Artery Disease;   Coronary Disease;   Myocardial Ischemia;   Arteriosclerosis;   Cardiovascular Diseases
Interventions:   Procedure: Fractional flow reserve-guided CABG;   Procedure: Angiography-guided CABG
Sponsor:   Odense University Hospital
Recruiting - verified June 2015

Patient and Provider Assessment of Lipid Management Registry

Conditions:   Hyperlipidemia;   Hypercholesterolemia;   Cardiovascular Disease;   Diabetes;   Chronic Kidney Disease (CKD);   Hypertension;   Smoking;   Myocardial Infarction (MI);   Unstable Angina;   Angina;   Coronary Artery Disease (CAD);   Stroke;   Transient Ischemic Attack (TIA);   Carotid Stenosis;   Peripheral Arterial Disease;   Atherosclerosis;   Claudication
Intervention:  
Sponsors:   Duke University;   Regeneron Pharmaceuticals;   Sanofi
Recruiting - verified June 2015

A Study of Evacetrapib (LY2484595) in Participants With High Cholesterol

Condition:   Hyperlipidemia
Interventions:   Drug: Evacetrapib;   Drug: Atorvastatin;   Drug: Ezetimibe;   Drug: Placebo
Sponsor:   Eli Lilly and Company
Recruiting - verified June 2015

Walking Effect of Long Term Ticagrelor in Subjects With PAD Who Have Undergone EVR

Condition:   Peripheral Artery Disease (PAD)
Interventions:   Drug: Ticagrelor;   Drug: Comparator
Sponsors:   AstraZeneca;   CPC Clinical Research
Recruiting - verified June 2015

Ethnicity and Onset of Cardiovascular Disease: A CALIBER Study

Conditions:   Abdominal Aortic Aneurysm;   Coronary Heart Disease;   Sudden Cardiac Death;   Intracerebral Haemorrhage;   Heart Failure;   Ischemic Stroke;   Myocardial Infarction;   Stroke;   Peripheral Arterial Disease;   Stable Angina Pectoris;   Subarachnoid Haemorrhage;   Transient Ischemic Attack;   Unstable Angina;   Cardiac Arrest
Intervention:  
Sponsors:   University College, London;   Wellcome Trust;   National Institute for Health Research, United Kingdom;   London School of Hygiene and Tropical Medicine
Active, not recruiting - verified July 2015

Ex Vivo Immunotherapy for Hyperglycemia in Type 2 Diabetes Mellitus

Conditions:   Type 2 Diabetes Mellitus;   Hyperglycemia
Intervention:   Drug: ex vivo Activated Immune Cells
Sponsors:   B & Y Technologies;   The 12th People's Hospital of Guangzhou City;   The 12th People's Hospital of Shenzhen City
Recruiting - verified June 2015

Using Feedback Reports to Improve Medication Adherence

Conditions:   Coronary Artery Disease;   Adherence
Interventions:   Behavioral: Individual Feedback;   Behavioral: Feedback Friend
Sponsor:   Philadelphia Veterans Affairs Medical Center
Recruiting - verified May 2014

Outcomes Study to Assess STatin Residual Risk Reduction With EpaNova in HiGh CV Risk PatienTs With Hypertriglyceridemia

Condition:   Eligible Men or Women Considered High Risk for Atherosclerotic Cardiovascular Disease (CVD)
Interventions:   Drug: Epanova® (omega-3 carboxylic acids);   Drug: corn oil control
Sponsors:   AstraZeneca;   The Cleveland Clinic
Recruiting - verified June 2015

The Use of Fish Oil to Reduce Inflammation Caused by a Peripheral Vascular Intervention

Condition:   Peripheral Arterial Disease
Interventions:   Dietary Supplement: Pro-Omega;   Other: Pro-Omega Placebo
Sponsor:   University of California, San Francisco
Recruiting - verified June 2015

Identification of CETP as a Marker of Atherosclerosis

Condition:   Cardiovascular Disease
Intervention:   Other: cardiovascular risk factors
Sponsor:   Institut National de la Santé Et de la Recherche Médicale, France
Recruiting - verified June 2015

Phase I Trial of Endocavitary Injection of Bone Marrow Derived CD133+ Cells in Ischemic Refractory Cardiomyopathy (RECARDIO Trial)

Condition:   Chronic Myocardial Ischemia
Intervention:   Other: Autologous bone marrow derived-CD133+ cells
Sponsors:   Centro Cardiologico Monzino;   Azienda Ospedaliera Città della Salute e della Scienza di Torino;   Azienda Ospedaliera San Gerardo di Monza
Recruiting - verified June 2015

Screening for Arteriopathy in General Medicine: a Preliminary Feasibility Study

Condition:   Peripheral Obliterative Arteriopathy
Interventions:   Other: First ultrasound reading;   Other: Second ultrasound interpretation
Sponsor:   Centre Hospitalier Universitaire de Nīmes
Recruiting - verified July 2015

Computational Tools for Early Diagnosis of Memory Disorders

Conditions:   Alzheimer Disease;   Frontotemporal Dementia;   Dementia, Vascular;   Mild Cognitive Impairment
Intervention:  
Sponsors:   University of Eastern Finland;   University of Sheffield;   VTT Technical Research Centre of Finland;   Klinik Hirslanden, Zurich;   Sheffield Teaching Hospitals NHS Foundation Trust
Active, not recruiting - verified June 2015

Intracoronary Infusion of Mononuclear Cells Autologous Bone Marrow in Patients With Chronic Coronary Occlusion and Ventricular Dysfunction, Previously Revascularized.

Condition:   Coronary Atherosclerosis and Other Heart Disease
Interventions:   Other: Mononuclear cells from autologous bone marrow;   Drug: Conventional medical treatment
Sponsors:   Andalusian Initiative for Advanced Therapies - Fundación Pública Andaluza Progreso y Salud;   Iniciativa Andaluza en Terapias Avanzadas 
Recruiting - verified June 2015

The Effects of Omega-3 Fatty Acids on Peripheral Arterial Disease II

Condition:   Peripheral Arterial Disease
Interventions:   Dietary Supplement: Pro-Omega;   Other: ProOmega Placebo
Sponsor:   University of California, San Francisco
Recruiting - verified June 2015

The Evaluation of Bococizumab (PF-04950615; RN316) in Reducing the Occurrence of Major Cardiovascular Events in High Risk Subjects

Condition:   Cardiovascular Disease
Interventions:   Drug: bococizumab (PF-04950615);   Drug: Placebo
Sponsor:   Pfizer
Recruiting - verified July 2015

The Evaluation of Bococizumab (PF-04950615;RN316) in Reducing the Occurrence of Major Cardiovascular Events in High Risk Subjects

Condition:   Cardiovascular Disease
Interventions:   Drug: bococizumab (PF-04950615);   Drug: Placebo
Sponsor:   Pfizer
Recruiting - verified July 2015

Global Study of a Drug-coated Balloon to Treat Obstructive SFA and/or Popliteal Lesions

Condition:   Peripheral Arterial Disease
Intervention:   Device: CVI Paclitaxel-Coated PTA Balloon Catheter
Sponsor:   Spectranetics Corporation
Active, not recruiting - verified June 2015

CVI Drug Coated Balloon European Randomized Clinical Trial

Conditions:   Peripheral Arterial Disease;   Claudication
Interventions:   Device: CVI Paclitaxel-coated Percutaneous Transluminal Angioplasty Balloon Catheter;   Device: Bare Percutaneous Transluminal Angioplasty Balloon Catheter
Sponsor:   Spectranetics Corporation
Active, not recruiting - verified June 2015

Tissue Removal Assessment With Ultrasound of THe SFA and Popliteal

Conditions:   Peripheral Artery Disease;   PAD;   Claudication;   Peripheral Vascular Disease;   PVD
Intervention:   Device: Stealth 360°® OAS
Sponsor:   Cardiovascular Systems Inc
Completed - verified May 2015

Complete Lesion Assessment With Fractional ffR and IVUS TechnologY

Conditions:   Peripheral Artery Disease;   Critical Limb Ischemia
Interventions:   Device: Orbital Atherectomy System;   Device: Balloon Angioplasty
Sponsor:   Cardiovascular Systems Inc
Completed - verified February 2015

Image Content Analysis of Dural-axis Rotational Versus Standard Coronary Angiography

Condition:   Coronary Artery Disease
Intervention:   Procedure: Coronary Angiography
Sponsor:   General Hospital of Chinese Armed Police Forces
Completed - verified June 2015

Intensive Rehabilitation in Peripheral Arterial Disease With Claudication: Effects of a Treadmill Training With Active Recovery

Conditions:   Peripheral Arterial Disease;   Claudication
Interventions:   Procedure: experimental rehabilitation program;   Procedure: conventional rehabilitation program
Sponsor:   University Hospital, Grenoble
Completed - verified June 2015

A Study to Evaluate the Effect of Aleglitazar on Cardiac Energetics and Function in Patients With Type 2 Diabetes Mellitus and no History of Coronary Artery Disease

Condition:   Diabetes Mellitus, Type 2
Interventions:   Drug: aleglitazar;   Drug: placebo
Sponsor:   Hoffmann-La Roche
Completed - verified July 2015

Prospective Characterization of the Heart, Aorta and Blood Pressure in Turner Syndrome. Association With Aortic Dissection.

Conditions:   Turner Syndrome;   Aortic Aneurysm;   Ischemic Heart Disease;   Hypertension;   Congenital Heart Defect
Intervention:  
Sponsor:   University of Aarhus
Recruiting - verified June 2015

Thyroid Hormone Replacement for Subclinical Hypothyroidism

Condition:   Subclinical Hypothyroidism
Interventions:   Drug: Levothyroxine;   Drug: Placebo
Sponsors:   NHS Greater Glasgow and Clyde;   University of Glasgow;   University College Cork;   University of Bern;   Leiden University Medical Center
Recruiting - verified July 2015

A Phase II Study of the Safety and Efficacy of MPSK3169A in Patients With Coronary Heart Disease or High Risk of Coronary Heart Disease

Condition:   Coronary Heart Disease
Interventions:   Drug: MPSK3169A;   Drug: MPSK3169A;   Drug: MPSK3169A;   Drug: MPSK3169A;   Drug: MPSK3169A;   Drug: Placebo
Sponsor:   Genentech, Inc.
Completed - verified July 2015

A Study of Dalcetrapib in Patients With Stable Coronary Heart Disease, With Coronary Heart Disease Risk Equivalents or at Elevated Risk for Cardiovascular Disease

Condition:   Cardiovascular Disease, Coronary Heart Disease, Dyslipidemia, Peripheral Arterial Disease (PAD)
Interventions:   Other: Background care;   Drug: Placebo;   Drug: dalcetrapib
Sponsor:   Hoffmann-La Roche
Completed - verified July 2015

Intracoronary Infusion of Bone Marrow Mononuclear Cells in Patients With Previous Myocardial Infarction.

Condition:   Chronic Myocardial Ischemia
Intervention:   Other: Bone marrow mononuclear cells
Sponsors:   Andalusian Initiative for Advanced Therapies - Fundación Pública Andaluza Progreso y Salud;   Iniciativa Andaluza en Terapias Avanzadas 
Completed - verified November 2014

A Study of Dalcetrapib in Patients Hospitalized For An Acute Coronary Syndrome (Dal-ACUTE)

Condition:   Coronary Heart Disease
Interventions:   Drug: dalcetrapib;   Drug: placebo
Sponsor:   Hoffmann-La Roche
Completed - verified July 2015

Influence of Varenicline on the Antiplatelet Action of Clopidogrel

Condition:   Coronary Artery Disease
Interventions:   Drug: Varenicline;   Behavioral: Counseling and psychosocial support
Sponsor:   General Hospital of Chinese Armed Police Forces
Recruiting - verified April 2015

A Study of RO4905417 in Patients Undergoing Coronary Artery Bypass Graft (CABG) Surgery

Condition:   Coronary Heart Disease, Graft Occlusion, Vascular
Interventions:   Drug: Placebo;   Drug: RO4905417
Sponsor:   Hoffmann-La Roche
Completed - verified July 2015

Randomized Trial of Imaging Versus Risk Factor-Based Therapy for Plaque Regression

Conditions:   Atherosclerosis;   Hypercholesterolemia
Interventions:   Drug: Statin Drugs;   Other: HMG-CoA Reductase Inhibitors
Sponsor:   National Institutes of Health Clinical Center (CC)
Active, not recruiting - verified April 2015

Cohort of Young Adults Infected With HIV Since Birth or During Childhood

Conditions:   HIV Infection;   Young Adult
Intervention:   Biological: blood sampling, specific biological exams and biobank and self administered questionnaires
Sponsor:   French National Agency for Research on AIDS and Viral Hepatitis
Recruiting - verified June 2015

Carpentier-Edwards PERIMOUNT Magna Ease Pericardial Bioprosthesis, Model 3300TFX

Conditions:   Coronary Artery Disease;   Aortic Valve Disorder;   Heart Failure;   Aortic Valve Stenosis;   Aortic Valve Insufficiency
Intervention:   Device: Implantation of CEP Magna Ease Model 3300TFX
Sponsor:   Edwards Lifesciences
Active, not recruiting - verified June 2015

Strategy for Adequate Blood Pressure Lowering in the Patients With Intracranial Atherosclerosis

Condition:   Brain Ischemia
Interventions:   Procedure: Aggressive BP lowering;   Procedure: modest blood pressure lowering
Sponsors:   Asan Medical Center;   Pfizer
Active, not recruiting - verified June 2015

TomVasc - Vascular Effects of Tomato Extract

Conditions:   Ischemic Heart Disease;   Transient Ischemic Attack;   Stroke;   Peripheral Vascular Disease
Interventions:   Dietary Supplement: Ateronon;   Dietary Supplement: Placebo
Sponsors:   Cambridge University Hospitals NHS Foundation Trust;   Cambridge Theranostics Ltd
Completed - verified July 2012

Integrated Dual Exercise and Lexiscan Positron Emission Tomography: IDEALPET

Condition:   Coronary Artery Disease
Interventions:   Drug: Exercise plus Regadenoson (Lexercise);   Drug: Regadenoson (Lexiscan)
Sponsor:   Brigham and Women's Hospital
Recruiting - verified June 2015

Safety and Efficacy Study of Autologous Concentrated Bone Marrow Aspirate (cBMA) for Critical Limb Ischemia (CLI)

Conditions:   Critical Limb Ischemia;   Peripheral Arterial Disease;   Peripheral Vascular Disease
Interventions:   Device: Bone marrow concentration device;   Procedure: Placebo procedure (sham)
Sponsor:   Biomet Biologics, LLC
Active, not recruiting - verified June 2015

Renal Function in Patients Submitted to Myocardial Revascularization Surgery

Condition:   Coronary Disease
Intervention:  
Sponsors:   UPECLIN HC FM Botucatu Unesp;   Faculdade de Medicina de Botucatu, UNESP, Botucatu, Brasil;   Coordenação de Aperfeiçoamento de Pessoal de Nível Superior.
Terminated - verified May 2009

Magna® Mitral Pericardial Bioprostheses Post-Approval Study Protocol

Conditions:   Coronary Artery Disease;   Mitral Valve Regurgitation;   Mitral Valve Incompetence;   Heart Failure
Intervention:   Device: CEP MAGNA MITRAL PERICARDIAL BIOPROSTHESES
Sponsor:   Edwards Lifesciences
Recruiting - verified July 2015

A Multiple Ascending Dose Study of RO4905417 in Healthy Volunteers and Patients With Peripheral Arterial Disease (PAD).

Condition:   Peripheral Arterial Disease (PAD)
Interventions:   Drug: RO4905417;   Drug: RO4905417;   Drug: RO4905417;   Drug: placebo;   Drug: placebo;   Drug: placebo
Sponsor:   Hoffmann-La Roche
Completed - verified July 2015

Investigating Superion™ In Spinal Stenosis

Conditions:   Lumbar Spinal Stenosis;   Intermittent Claudication
Interventions:   Device: Superion™ Interspinous Spacer;   Device: X-STOP® IPD® Device
Sponsor:   VertiFlex, Incorporated
Active, not recruiting - verified January 2015

A Study of the Effect of RO4607381 on Atherosclerotic Plaque in Patients With Coronary Heart Disease

Condition:   Coronary Heart Disease
Interventions:   Drug: Placebo;   Drug: dalcetrapib
Sponsor:   Hoffmann-La Roche
Completed - verified July 2015

A Study of RO4607381 in Stable Coronary Heart Disease Patients With Recent Acute Coronary Syndrome

Condition:   Coronary Heart Disease
Interventions:   Drug: Evidence-based medical care for Acute Coronary Syndrome;   Drug: Placebo;   Drug: dalcetrapib
Sponsor:   Hoffmann-La Roche
Completed - verified July 2015

A Study Assessing the Effect of RO4607381 on Vascular Function in Patients With Coronary Heart Disease (CHD) or CHD-Risk Equivalent Patients

Condition:   Coronary Heart Disease
Interventions:   Drug: Placebo;   Drug: dalcetrapib
Sponsor:   Hoffmann-La Roche
Completed - verified July 2015

ACT34-CMI -- Adult Autologous CD34+ Stem Cells (Follow-Up Study)

Condition:   Myocardial Ischemia
Intervention:  
Sponsor:   Baxalta US Inc.
Completed - verified July 2010

A Long Term Extension of Study NC19453 Evaluating Safety and Efficacy of RO4607381

Condition:   Coronary Heart Disease
Interventions:   Drug: Placebo;   Drug: dalcetrapib
Sponsor:   Hoffmann-La Roche
Completed - verified July 2015

Inflammatory Response During Anesthesia and Surgery

Conditions:   Systemic Inflammatory Response Syndrome;   Myocardial Ischemia
Intervention:  
Sponsors:   UMC Utrecht;   European Association of Cardiothoracic Anaesthesiologists
Completed - verified June 2008

A Study of RO4607381 in Patients With Coronary Heart Disease (CHD) or a CHD Risk Equivalent.

Condition:   Coronary Heart Disease
Interventions:   Drug: Placebo;   Drug: dalcetrapib
Sponsor:   Hoffmann-La Roche
Completed - verified July 2015

Vascular Aging: The Link That Bridges Age to Atherosclerosis (The VALIDATE Study)

Conditions:   Atherosclerosis;   Cardiovascular Disease;   Vascular Diseases
Intervention:  
Sponsor:   National Institute on Aging (NIA)
Active, not recruiting - verified May 2015

Get CardioSmart

You're Invited